Results from the first long-term follow-up study of an oral vaccine for recurrent urinary tract infections (UTIs) suggest that it “could be a gamechanger for UTI prevention,” according to consultant urologist Bob Yang, who co-led the trial. “It’s very exciting… for us it was almost magical,” said Yang, who works with […]
Gracias a décadas de estrategias de control de vectores exitosas, la transmisión vectorial de la enfermedad de Chagas disminuyó significativamente en muchas regiones, aunque la ingestión oral de Trypanosoma cruzi a través de alimentos y bebidas contaminados se describe cada vez más y, a diferencia de la transmisión por vectores, la enfermedad de Chagas […]
Syphilis is an infection caused by the bacterium Treponema pallidum. Syphilis is a sexually transmitted infection that is acquired through genital, oral, or anal sex. Syphilis can also be passed to a fetus during pregnancy, causing congenital syphilis. Early diagnosis and treatment of syphilis is important to prevent progression of […]
Patients with mild to moderate COVID-19 who were treated for 5 days with VV116, an investigational oral antiviral drug that is active against SARS-CoV-2, recovered as quickly from infection as did those treated with nirmatrelvir-ritonavir (Paxlovid), according to the results of a randomized noninferiority trial published in the New England […]
A single pill of the investigational drug molnupiravir taken twice a day for 5 days eliminated SARS-CoV-2 from the nasopharynx of 49 participants. That led Carlos del Rio, MD, distinguished professor of medicine at Emory University in Atlanta, Georgia, to suggest a future in which a drug like molnupiravir could be […]
A single pill of the investigational drug molnupiravir taken twice a day for 5 days eliminated SARS-CoV-2 from the nasopharynx of 49 participants. That led Carlos del Rio, MD, distinguished professor of medicine at Emory University in Atlanta, Georgia, to suggest a future in which a drug like molnupiravir could be […]
A single pill of the investigational drug molnupiravir taken twice a day for 5 days eliminated SARS-CoV-2 from the nasopharynx of 49 participants. That led Carlos del Rio, MD, distinguished professor of medicine at Emory University in Atlanta, Georgia, to suggest a future in which a drug like molnupiravir could be […]
A coronavirus vaccine that could be taken as a pill may enter clinical trials in the second quarter of 2021. The oral vaccine is being developed by Oravax Medical, a new joint venture of the Israeli-American company Oramed and the Indian company Premas Biotech, Business Insider reported. So far, all […]
